Clinical profile of patients initiating evolocumab in Spanish Cardiology Units: A RETrospective, Observational Study of Real-World Clinical Practice (RETOSS-Cardio)

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Professor Vivencio Barrios

Ramon and Cajal University Hospital, Madrid (Spain)

14 More presentations in this session

Presentation thumbnail

Blood pressure and LDL-cholesterol control in patients with primary hypertension is far from optimal: results from a large observational, multicentric, prospective study

Professor D. Vinereanu (Bucharest, RO)

Presentation thumbnail

High density lipoprotein cholesterol (HDL-C) levels and endothelial glycocalyx integrity in treated hypertensive patients

Doctor H. Triantafyllidi (Athens, GR)

Abstract Slides

Presentation thumbnail

Triglycerides are related to left ventricular mass in hypertensive patients, independently of other cardiometabolic risk factors: The effect of gender

Presentation thumbnail

Optimal serum uric acid levels for hypertension:5-year cohort study

Associate Professor M. Kuwabara (Shimotsuke, JP)

Abstract Slides

Presentation thumbnail

Elevated serum uric acid associated with hypertension in healthy individuals

Doctor C. Liu (Taipei, TW)

Access the full session

Session thumbnail

Poster Session 2 - Hypertension risk factors and life style

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?

Congress Presentation

The floor is yours: bring your questions about optimal blood pressure control for organ protection - expert panel

Congress Presentation

Hypertension and glucose

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources